Marksans Pharma Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended March 31, 2026. The Registrar and Transfer Agent, Bigshare Services Private Limited, confirmed that securities received from depository participants for dematerialization up to March 31, 2026, were processed (accepted/rejected) by them. These securities are listed on the stock exchange where the company's existing securities are listed. Furthermore, Bigshare Services Private Limited confirmed that the security certificates received for dematerialization have been duly verified, mutilated, and cancelled. The depositories' names have been substituted as the registered owners in the company's register of members within 15 days of receiving the securities.
